<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">467938598</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180406153005.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">170328e20060801xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s10822-006-9065-z</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s10822-006-9065-z</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Modeling and active site refinement for G protein-coupled receptors: application to the β-2 adrenergic receptor</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Stanley Krystek Jr, S. Kimura, Andrew Tebben]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">It is well known that G protein-coupled receptors are prime targets for drug discovery. At the present time there is only one protein from this class that has an X-ray crystal structure, bovine rhodopsin. Crystal structures of rhodopsin have become invaluable templates for the modeling of class-A G protein-coupled receptors as they likely represent the overall topology of this family of proteins. However, because of low sequence homology within the class and the inherent mobility of integral membrane proteins, it is unlikely that this single structural template reflects the ensemble of conformations accessible for any given receptor. We have devised a procedure based upon comparative modeling that uses induced fit modeling coupled with binding site expansion. The modeling protocol enables an ensemble approach to binding mode prediction. The utility of models for β-2 adrenergic receptor will be discussed.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">Springer Science+Business Media B.V., 2006</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">GPCR</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Protein modeling</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Comparative modeling</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">GPCR structure</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Krystek Jr</subfield>
   <subfield code="D">Stanley</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Kimura</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Tebben</subfield>
   <subfield code="D">Andrew</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Journal of Computer-Aided Molecular Design</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">20/7-8(2006-08-01), 463-470</subfield>
   <subfield code="x">0920-654X</subfield>
   <subfield code="q">20:7-8&lt;463</subfield>
   <subfield code="1">2006</subfield>
   <subfield code="2">20</subfield>
   <subfield code="o">10822</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s10822-006-9065-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s10822-006-9065-z</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Krystek Jr</subfield>
   <subfield code="D">Stanley</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Kimura</subfield>
   <subfield code="D">S.</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Tebben</subfield>
   <subfield code="D">Andrew</subfield>
   <subfield code="u">Department of Molecular Biosciences, Bristol-Myers Squibb Pharmaceutical Research Institute, P.O. Box 5400, 08543-5400, Princeton, NJ, USA</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Journal of Computer-Aided Molecular Design</subfield>
   <subfield code="d">Kluwer Academic Publishers</subfield>
   <subfield code="g">20/7-8(2006-08-01), 463-470</subfield>
   <subfield code="x">0920-654X</subfield>
   <subfield code="q">20:7-8&lt;463</subfield>
   <subfield code="1">2006</subfield>
   <subfield code="2">20</subfield>
   <subfield code="o">10822</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
 </record>
</collection>
